Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New York, NY
SEC filing record 1 source field available
Fiscal year end
31 December
Protara Therapeutics, Inc. has filed 805 SEC EDGAR filings since 14 Apr 2006

SEC filing history

Showing 151-175 of 800 matching filings.

Per page
25
Current page
7
4

4 filing

Filing date
18 Jul 2024
Reporting date
16 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
11 Jul 2024
Reporting date
09 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 Jul 2024
Reporting date
01 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
28 Jun 2024
Reporting date
27 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
27 Jun 2024
Reporting date
25 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
10 Jun 2024
Reporting date
07 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
10 Jun 2024
Reporting date
07 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
10 Jun 2024
Reporting date
07 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
10 Jun 2024
Reporting date
07 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
10 Jun 2024
Reporting date
07 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
10 Jun 2024
Reporting date
07 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
10 Jun 2024
Reporting date
07 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
10 Jun 2024
Reporting date
07 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36694

CURRENT REPORT

Filing date
10 Jun 2024
Reporting date
07 Jun 2024
Next action
Verify source filing
4

4 filing

Filing date
31 May 2024
Reporting date
30 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
23 May 2024
Reporting date
21 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 May 2024
Reporting date
17 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
10 May 2024
Reporting date
09 May 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-279067

EFFECT filing

Filing date
09 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-279067

PROSPECTUS

Filing date
09 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
07 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-279067

UPLOAD filing

Filing date
07 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-279067

REGISTRATION STATEMENT

Filing date
02 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-36694

QUARTERLY REPORT

Filing date
02 May 2024
Reporting date
31 Mar 2024
Next action
Verify source filing
8-K File 001-36694

CURRENT REPORT

Filing date
02 May 2024
Reporting date
02 May 2024
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .